ReShape Lifesciences | 10-Q: FY2025 Q2 Revenue: USD 1.242 M

12 Health Care Stocks Moving In Wednesday's Intraday Session

In Wednesday's intraday session, several health care stocks saw significant movements. Generation Bio (GBIO) surged 52.5% to $6.17, with a market cap of $27.1 million following its Q2 earnings report. Reshape Lifesciences (RSLS) rose 52.46% to $3.1, while Editas Medicine (EDIT) increased by 34.98% to $3.09, both also reporting Q2 earnings. Ovid Therapeutics (OVID) shares climbed 34.05% to $0.73, and Sonnet BioTherapeutics (SONN) rose 30.41% to $3.9. Arcturus Therapeutics (ARCT) saw a 27.6% increase to $19.0, with a market cap of $403.8 million.

ReShape Lifesciences Announces 1-for-4 Reverse Stock Split Effective August 15, 2025

ReShape Lifesciences Inc. has announced a 1-for-4 reverse stock split effective August 15, 2025, consolidating every four shares into one. Following this change, the new CUSIP number will be 92943X104. This stock split is part of the company's merger with Vyome Therapeutics, after which it will be listed as Vyome Holdings, Inc. under the symbol "HIND."

ReShape Lifesciences Shareholders Approve Merger with Vyome Therapeutics, Effective August 15, 2025

ReShape Lifesciences Inc. shareholders have approved the merger with Vyome Therapeutics, effective August 15, 2025. The combined company will trade as Vyome Holdings, Inc. on The Nasdaq Capital Market under the symbol "HIND." This merger aims to create a healthcare platform across the US-India innovation corridor, with both companies receiving support from financial advisors and legal counsel for a smooth transition.

ReShape Lifesciences® Announces Partial Adjournment of Special Meeting of Stockholders

Partial Adjournment for Proposal 2, Asset Sale Proposal, and Proposal 3, Charter Amendment Proposal; All Other Proposals Required for Merger Were Approved Stockholders are encouraged to vote FOR Proposals 2 and 3 by Calling 1-877-750-8310 ( from the U.S. and Canada ) or +1-412-232-3651 ( from ...